INFEX Therapeutics Revenue and Competitors
Employee Data
- INFEX Therapeutics has 23 Employees.
- INFEX Therapeutics grew their employee count by 5% last year.
INFEX Therapeutics's People
| Name | Title | Email/Phone |
|---|
INFEX Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.5M | 29 | -12% | N/A | N/A |
#2 | $15.7M | 86 | 4% | N/A | N/A |
#3 | $87.9M | 405 | 25% | $292M | N/A |
#4 | $2.6M | 680 | 30% | $631.7M | N/A |
#5 | $14.9M | 96 | -8% | $81M | N/A |
#6 | $44.8M | 231 | 0% | $132.9M | N/A |
#7 | $7.6M | 49 | -37% | N/A | N/A |
#8 | $17.4M | 112 | 12% | N/A | N/A |
#9 | $334.6M | 1349 | 11% | £994.6M | N/A |
#10 | $830.2M | 5095 | 12% | N/A | N/A |
What Is INFEX Therapeutics?
We acquire, develop and license innovative drugs to treat pandemic infections. We have expanded to develop a broader portfolio of new therapies to meet the rising burden of critical priority infectious disease. Based at Alderley Park in the North West of England, our work addresses unmet patient needs and will bring new portfolio of drugs into clinical trials to treat patients suffering from life-threatening infections.
keywords:N/A
N/A
Total Funding
23
Number of Employees
N/A
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Alderley Edge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.4M | 29 | 61% | N/A |
#2 | $8.9M | 43 | 19% | N/A |
#3 | $13.5M | 45 | -18% | N/A |
#4 | $5.7M | 49 | N/A | N/A |
#5 | $6.3M | 69 | 41% | N/A |